Department of Molecular Pharmacology & Physiology, Byrd Alzheimer Institute, University of South Florida, Tampa, FL, USA.
J Neuroinflammation. 2013 Jul 17;10:86. doi: 10.1186/1742-2094-10-86.
The chemokine (C-C motif) ligand 2 (CCL2) is a monocyte chemoattractant protein that mediates macrophage recruitment and migration during peripheral and central nervous system (CNS) inflammation.
To determine the impact of CCL2 in inflammation in vivo and to elucidate the CCL2-induced polarization of activated brain microglia, we delivered CCL2 into the brains of wild-type mice via recombinant adeno-associated virus serotype 9 (rAAV-9) driven by the chicken β-actin promoter. We measured microglial activation using histological and chemical measurement and recruitment of monocytes using histology and flow cytometry.
The overexpression of CCL2 in the CNS induced significant activation of brain resident microglia. CD45 and major histocompatibility complex class II immunoreactivity significantly increased at the sites of CCL2 administration. Histological characterization of the microglial phenotype revealed the elevation of "classically activated" microglial markers, such as calgranulin B and IL-1β, as well as markers associated with "alternative activation" of microglia, including YM1 and arginase 1. The protein expression profile in the hippocampus demonstrated markedly increased levels of IL-6, GM-CSF and eotaxin (CCL-11) in response to CCL2, but no changes in the levels of other cytokines, including TNF-α and IFN-γ. Moreover, real-time PCR analysis confirmed increases in mRNA levels of gene transcripts associated with neuroinflammation following CCL2 overexpression. Finally, we investigated the chemotactic properties of CCL2 in vivo by performing adoptive transfer of bone marrow-derived cells (BMDCs) isolated from donor mice that ubiquitously expressed green fluorescent protein. Flow cytometry and histological analyses indicated that BMDCs extravasated into brain parenchyma and colabeled with microglial markers.
Taken together, our results suggest that CCL2 strongly activates resident microglia in the brain. Both pro- and anti-inflammatory activation of microglia were prominent, with no bias toward the M1 or M2 phenotype in the activated cells. As expected, CCL2 overexpression actively recruited circulating monocytes into the CNS. Thus, CCL2 expression in mouse brain induces microglial activation and represents an efficient method for recruitment of peripheral macrophages.
趋化因子(C-C 基序)配体 2(CCL2)是一种单核细胞趋化蛋白,可介导周围和中枢神经系统(CNS)炎症期间巨噬细胞的募集和迁移。
为了确定 CCL2 在体内炎症中的作用,并阐明 CCL2 诱导激活的脑小胶质细胞的极化,我们通过鸡β-肌动蛋白启动子驱动的重组腺相关病毒血清型 9(rAAV-9)将 CCL2 递送到野生型小鼠的大脑中。我们使用组织化学测量法测量小胶质细胞的激活,并用组织学和流式细胞术测量单核细胞的募集。
CCL2 在中枢神经系统中的过表达可显著诱导脑驻留小胶质细胞的激活。在 CCL2 给药部位,CD45 和主要组织相容性复合体 II 免疫反应性显著增加。小胶质细胞表型的组织学特征表明,上调了“经典激活”小胶质细胞标志物,如钙粒蛋白 B 和 IL-1β,以及与小胶质细胞“替代激活”相关的标志物,包括 YM1 和精氨酸酶 1。海马体中的蛋白质表达谱显示,IL-6、GM-CSF 和嗜酸性粒细胞趋化因子(CCL-11)的水平在 CCL2 反应中显著增加,但其他细胞因子(包括 TNF-α和 IFN-γ)的水平没有变化。此外,实时 PCR 分析证实,CCL2 过表达后,与神经炎症相关的基因转录本的 mRNA 水平增加。最后,我们通过对来自普遍表达绿色荧光蛋白的供体小鼠分离的骨髓来源细胞(BMDC)进行过继转移,在体内研究了 CCL2 的趋化特性。流式细胞术和组织学分析表明,BMDC 渗出到脑实质并与小胶质细胞标志物共标记。
综上所述,我们的结果表明 CCL2 可强烈激活大脑中的驻留小胶质细胞。小胶质细胞的促炎和抗炎激活都很明显,在激活的细胞中没有偏向 M1 或 M2 表型。如预期的那样,CCL2 过表达可将循环单核细胞主动募集到中枢神经系统中。因此,小鼠大脑中的 CCL2 表达诱导小胶质细胞激活,并代表募集外周巨噬细胞的有效方法。